You're viewing our updated article page. If you need more time to adjust, you can return to the old layout.

CORRECTION article

Front. Chem., 10 December 2025

Sec. Medicinal and Pharmaceutical Chemistry

Volume 13 - 2025 | https://doi.org/10.3389/fchem.2025.1748491

Correction: Design, synthesis, antiproliferative assessments, and computational studies of new quinolin-2(1H)-ones as dual EGFR/HER-2 inhibitors

  • 1. Department of Chemistry, College of Sciences, Princess Nourah bint Abdulrahman University, Riyadh, Saudi Arabia

  • 2. Medicinal Chemistry Department, Faculty of Pharmacy, Deraya University, Minia, Egypt

  • 3. Department of Chemistry, University of Helsinki, Helsinki, Finland

  • 4. Institute of Biological and Chemical Systems, IBCS-FMS, Karlsruhe Institute of Technology, Karlsruhe, Germany

  • 5. Department of Pharmaceutical Organic Chemistry, Faculty of Pharmacy, Assiut University, Assiut, Egypt

  • 6. Chemistry Department, Faculty of Science, Minia University, El-Minia, Egypt

  • 7. Unit of Occupational of Safety and Health, Administration Office of Minia University, El-Minia, Egypt

Article metrics

View details

937

Views

38

Downloads

An incorrect Funding statement was provided. The funding details were erroneously given in the Acknowledgments statement. The correct Funding statement reads:

The authors declare that financial support was received for the research and/or publication of this article. This work was funded by Princess Nourah bint Abdulrahman University Researchers Supporting Project Number (PNURSP2025R3), Princess Nourah bint Abdulrahman University, Riyadh, Saudi Arabia, and the KIT-Publication Fund of the Karlsruhe Institute of Technology.

The middle initial for author Hendawy N. Tawfeek was missing and this author’s surname was also misspelled as “Tawfik”.

The original article has been updated.

Statements

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Summary

Keywords

quinoline, kinases, X-ray, DFT, anticancer, EGFR, HER-2

Citation

Al-Wahaibi LH, Abou-Zied HA, Nieger M, Bräse S, Youssif BGM and Tawfeek HN (2025) Correction: Design, synthesis, antiproliferative assessments, and computational studies of new quinolin-2(1H)-ones as dual EGFR/HER-2 inhibitors. Front. Chem. 13:1748491. doi: 10.3389/fchem.2025.1748491

Received

17 November 2025

Revised

26 November 2025

Accepted

26 November 2025

Published

10 December 2025

Approved by

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Volume

13 - 2025

Updates

Copyright

*Correspondence: Bahaa G. M. Youssif, ; Stefan Bräse,

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics